Qiangqiang Yin
Overview
Explore the profile of Qiangqiang Yin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Li N, Yin Q, Zhang Z, Hu H, Hao L
Sci Rep
. 2025 Feb;
15(1):7217.
PMID: 40021813
This project aims to construct cRGD functionalized mesoporous silica nanoparticles and cRGD modified mesoporous silica nanoparticles for the diagnosis and treatment of tumors, providing new ideas for targeted therapy of...
2.
Cheng J, Hao L, Zhu X, Ma R, Li S, Yin Q, et al.
J Biomed Mater Res A
. 2024 Dec;
113(1):e37847.
PMID: 39668797
Triggered by the vulnerability to atherosclerotic plaques, cardiovascular diseases (CVDs) have become a main reason for high mortality worldwide. Thus, there is an urgent need to develop functional molecular imaging...
3.
Yin Q, Gao X, Zhang H, Zhang Z, Yu X, He J, et al.
Biomed Mater
. 2024 Apr;
19(3).
PMID: 38626777
This study developed a probe FeO-Cy5.5-trastuzumab with fluorescence and magnetic resonance imaging functions that can target breast cancer with high HER2 expression, aiming to provide a new theoretical method for...
4.
Ma R, Hao L, Cheng J, He J, Yin Q, Li Z, et al.
Biochem Biophys Res Commun
. 2024 Feb;
702:149627.
PMID: 38340655
Rupture of vulnerable plaque and secondary thrombosis caused by atherosclerosis are one of the main causes of acute cardiovascular and cerebrovascular events, and it is urgent to develop an in-situ,...
5.
Qi G, Shi G, Wang S, Hu H, Zhang Z, Yin Q, et al.
Int J Nanomedicine
. 2023 Dec;
18:7133-7147.
PMID: 38054080
Introduction: This study developed a pancreatic cancer targeted drug delivery system that responds to changes in acidity. The system was based on iron oxide core-shell magnetic mesoporous silica nanoparticles (M-MSNs)...
6.
Wang S, Qi G, Zhang Z, Yin Q, Li N, Li Z, et al.
Molecules
. 2023 Aug;
28(16).
PMID: 37630386
Clinically, magnetic resonance imaging (MRI) often uses contrast agents (CAs) to improve image contrast, but single-signal MRI CAs are often susceptible to calcification, hemorrhage, and magnetic sensitivity. Herein, iron acetylacetone...
7.
Shi G, Li Z, Zhang Z, Yin Q, Li N, Wang S, et al.
Biochem Biophys Res Commun
. 2023 Jul;
674:1-9.
PMID: 37392717
In an effort to enhance the antitumor efficacy of breast cancer treatment, the chemotherapeutic agent Paclitaxel (PTX) was encapsulated within hyaluronic acid (HA) modified hollow mesoporous silica (HMSNs). In vitro...
8.
Yin Q, Qi G, Wang S, Tian H, Gao X, Zhang Z, et al.
Biochem Biophys Res Commun
. 2023 May;
664:86-93.
PMID: 37141641
Pancreatic ductal adenocarcinoma (PDAC) is a malignant digestive system tumor with a poor late-stage prognosis. This study aimed to identify new methods for the early detection of PDAC. The nanoprobe...